AIT Austrian Institute of Technology GmbH-医療機器分野:企業M&A・提携分析

◆英語タイトル:AIT Austrian Institute of Technology GmbH - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011292
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AIT Austrian Institute of Technology GmbH (AIT) is a research and technology institute that provides research development services in various fields. The institute offers research on health and environment, energy, mobility, digital safety and security, and innovation systems. Its health and environment research services include biomedical and bio molecular solutions, biological resources database, microbial detection and water treatment, among others. It offers services for the preparation of smart grids, photovoltaics, thermal energy systems, smart cities and develops business models in mobility, and digital safety and security. The institute also offers research services in the areas of innovation systems modeling, studies and foresight from various segments. It operates in Vienna, Wiener Neustadt, Braunau am Inn, Graz, Hall in Tirol and Tulln, Austria. AIT is headquartered in Vienna, Austria.

AIT Austrian Institute of Technology GmbH – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
AIT Austrian Institute of Technology GmbH, Medical Equipment Deals By Type, 2011 to YTD 2017 6
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deal Details 10
Partnerships 10
Blue Earth Diagnostics and Seibersdorf Lab Enters into Distribution Agreement 10
Nanyang Technological University Enters into Research Agreement with Austrian Institute of Technology and Medical University of Vienna 11
Caprion Biosciences, Asuragen and AIT Austrian Institute of Technology Enter into Agreement with Cancer Research and Abcodia 12
AIT Austrian Institute Enters into Co-Development Agreement with BioVendor and Scienion 14
RiboMed Enters Into Development Agreement With Austrian Institute Of Technology For Lung Cancer Assay 15
Abcodia Partners with AIT Austrian Institute of Technology 16
AIT Austrian Institute of Technology GmbH – Key Competitors 17
AIT Austrian Institute of Technology GmbH – Key Employees 18
AIT Austrian Institute of Technology GmbH – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
AIT Austrian Institute of Technology GmbH, Medical Equipment, Key Facts 2
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
AIT Austrian Institute of Technology GmbH, Medical Equipment Deals By Type, 2011 to YTD 2017 6
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
AIT Austrian Institute of Technology GmbH, Deals By Market, 2011 to YTD 2017 8
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Blue Earth Diagnostics and Seibersdorf Lab Enters into Distribution Agreement 10
Nanyang Technological University Enters into Research Agreement with Austrian Institute of Technology and Medical University of Vienna 11
Caprion Biosciences, Asuragen and AIT Austrian Institute of Technology Enter into Agreement with Cancer Research and Abcodia 12
AIT Austrian Institute Enters into Co-Development Agreement with BioVendor and Scienion 14
RiboMed Enters Into Development Agreement With Austrian Institute Of Technology For Lung Cancer Assay 15
Abcodia Partners with AIT Austrian Institute of Technology 16
AIT Austrian Institute of Technology GmbH, Key Competitors 17
AIT Austrian Institute of Technology GmbH, Key Employees 18
AIT Austrian Institute of Technology GmbH, Other Locations 20
AIT Austrian Institute of Technology GmbH, Subsidiaries 20

★海外企業調査レポート[AIT Austrian Institute of Technology GmbH-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Orgenesis Inc (ORGS):製薬・医療:M&Aディール及び事業提携情報
    Summary Orgenesis Inc (Orgenesis) is a biopharmaceutical company that focuses on the development and manufacturing of regenerative cellular therapy and medicine for the treatment of insulin-dependent diabetes patients. The company, through its subsidiaries, offers contract development and manufactur …
  • Galectin Therapeutics Inc (GALT):医療機器:M&Aディール及び事業提携情報
    Summary Galectin Therapeutics Inc (Galectin Therapeutics), formerly Pro-Pharmaceuticals Inc is a biotechnology company that discovers, develops and commercializes therapies for fibrotic disease and cancer. The company provides products such as GR-MD-02, GM-CT-01, and others. Its GR-MD-02 is a drug c …
  • Neurosigma Inc:企業の製品パイプライン分析
    Summary Neurosigma Inc (Neurosigma) is a life science company that develops and commercializes trigeminal nerve stimulation technologies for neurologic and psychiatric disorders. It offers Monarch eTNS System for treatment of pediatric Attention Deficit Hyperactivity Disorder (ADHD). The company off …
  • IOI Corp Berhad (IOICORP):企業の財務・戦略的SWOT分析
    IOI Corp Berhad (IOICORP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sumitomo Mitsui Trust Holdings Inc
    Sumitomo Mitsui Trust Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Mitsui Trust Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • GVK Biosciences Pvt Ltd-製薬・医療分野:企業M&A・提携分析
    Summary GVK Biosciences Pvt Ltd (GVK BIO) is a contract research organization that offers contract manufacturing and research services. The organization provides services such as discovery services, integrated programs, clinical development, contract manufacturing, formulations and informatics. It p …
  • Dilafor AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Dilafor AB (Dilafor) is a drug development company that develops pharmaceutical products for obstetric indications. The company offers tafoxiparin, a proprietary heparan sulfate mimetic, which is used as an adjuvant therapy to promote cervical ripening and myometrial contractility. Its tafox …
  • Alaska Air Group, Inc.:企業の戦略・SWOT・財務情報
    Alaska Air Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alaska Air Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Suburban Propane Partners, L.P.:企業の戦略・SWOT・財務情報
    Suburban Propane Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Suburban Propane Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Shelby Energy Cooperative, Inc.:企業の発電所・SWOT分析2018
    Shelby Energy Cooperative, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …
  • Wynn Macau Ltd:企業の戦略・SWOT・財務分析
    Wynn Macau Ltd - Strategy, SWOT and Corporate Finance Report Summary Wynn Macau Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • iMedX Inc-医療機器分野:企業M&A・提携分析
    Summary iMedX Inc (iMedX) is a provider of medical document management and health information solutions. The company offers transcription services and coding services. It provides iMedX Express web based platforms and iMedX Mobile with DocAssist applications. iMedX’s transcription services comprise …
  • Microsemi Corp:企業の戦略的SWOT分析
    Microsemi Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • CS Communication & Systemes SA:企業の戦略・SWOT・財務分析
    CS Communication & Systemes SA - Strategy, SWOT and Corporate Finance Report Summary CS Communication & Systemes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Sernova Corp (SVA):医療機器:M&Aディール及び事業提携情報
    Summary Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company develops Cell Pouch System, an implantable medical device, which offers a natural organ-like …
  • Herantis Pharma Plc (HRTIS):企業の財務・戦略的SWOT分析
    Summary Herantis Pharma Plc (Herantis Pharma) operates as a drug development company that offers regenerative medicine for neurodegenerative diseases. The company's pipeline products include CDNF for amyotrophic lateral sclerosis, CDNF for Parkinson’s disease and lymfactin for secondary lymphedema. …
  • TOTAL S.A.:企業のM&A・事業提携・投資動向
    TOTAL S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TOTAL S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Inovio Pharmaceuticals Inc (INO):企業の財務・戦略的SWOT分析
    Inovio Pharmaceuticals Inc (INO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Time Dotcom Berhad (TIMECOM):企業の財務・戦略的SWOT分析
    Time Dotcom Berhad (TIMECOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Extreme Networks Inc (EXTR):企業の財務・戦略的SWOT分析
    Extreme Networks Inc (EXTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆